- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Epoetin alfa RB
Total 3162 results
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...CompletedNasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing CarinomaHong Kong
-
AmgenCompletedInflammatory DiseasesUnited Kingdom
-
University of Turin, ItalyCompleted
-
University Hospital TuebingenJoachim Riethmueller, Dr. med.UnknownLong Term VentilationGermany
-
PharmaEssentiaRecruitingPolycythemia VeraUnited States, Canada
-
Nicole HamblettUniversity of Washington; Dartmouth-Hitchcock Medical Center; Cystic Fibrosis...Completed
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Kyowa Kirin Co., Ltd.Completed
-
AmgenCompletedLymphoma | Breast Neoplasms | Lung Neoplasms | Multiple Myeloma | Chronic Lymphocytic Leukemia
-
AmgenCompleted
-
Chugai PharmaceuticalCompleted
-
AM-PharmaCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Kyowa Kirin Co., Ltd.Completed
-
Shahid Beheshti University of Medical SciencesUnknownNon-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Iran, Islamic Republic of
-
Fresenius Medical Care North AmericaTerminated
-
Eunice Kennedy Shriver National Institute of Child...UnknownCancerUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingMyasthenia Gravis
-
Denali Therapeutics Inc.Enrolling by invitationMucopolysaccharidosis IIUnited States, Canada, Belgium, Czechia, Netherlands
-
Denali Therapeutics Inc.Active, not recruitingMucopolysaccharidosis IIUnited States, Netherlands, Canada, United Kingdom
-
PfizerCompleted
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.AvailableFabry DiseaseUnited States
-
Alexion PharmaceuticalsWithdrawn
-
Hoffmann-La RocheCompleted
-
SanofiRecruitingAcid Sphingomyelinase Deficiency (ASMD)France
-
Queen Mary University of LondonNot yet recruitingTransitional Cell Carcinoma | Bladder Cancer
-
GlaxoSmithKlineMerck KGaA, Darmstadt, GermanyTerminatedNeoplasmsSpain, United States, France, Netherlands, Canada
-
Universitair Ziekenhuis BrusselCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
AmgenCompletedAnemia | Chronic Kidney DiseaseFrance, Italy, United Kingdom, Belgium, Hungary, Spain, Israel, Portugal, Bulgaria, Serbia, Poland, Romania, Greece, Australia, Denmark, Russian Federation, Slovakia, Germany, Latvia, Estonia, Slovenia, Czech Republic, Mexico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, Ireland, Italy, United Kingdom
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseAustralia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
-
ISU Abxis Co., Ltd.Catalyst BiosciencesCompletedHemophilia BKorea, Republic of
-
AmgenCompletedChronic Kidney Disease | Kidney Disease
-
Institut Universitari DexeusCompleted
-
The Immunobiological Technology Institute (Bio-Manguinhos)...CompletedChronic Viral Hepatitis CBrazil
-
Centre Hospitalier Universitaire, AmiensRoche Pharma AGCompletedKidney Failure | Renal Transplantation | AnaemiaFrance
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
Cardiovascular Imaging TechnologiesAstellas Pharma US, Inc.UnknownCoronary Artery DiseaseUnited States
-
Denali Therapeutics Inc.RecruitingMucopolysaccharidosis IIUnited States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Brazil, Colombia
-
National Cancer Institute (NCI)Active, not recruitingOlfactory Neuroblastoma | Esthesioneuroblastoma | Neoplasm of the Nasal CavityUnited States
-
SanofiApproved for marketing